SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-009086
Filing Date
2016-11-02
Accepted
2016-11-02 16:51:34
Documents
58
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q immu-20160930x10q.htm 10-Q 1255581
2 EX-31.1 immu-20160930ex311fcf68c.htm EX-31.1 15326
3 EX-31.2 immu-20160930ex3124fbf06.htm EX-31.2 16207
4 EX-32.1 immu-20160930ex321a0df4f.htm EX-32.1 12294
  Complete submission text file 0001558370-16-009086.txt   5454762

Data Files

Seq Description Document Type Size
5 EX-101.INS immu-20160930.xml EX-101.INS 1282905
6 EX-101.SCH immu-20160930.xsd EX-101.SCH 33391
7 EX-101.CAL immu-20160930_cal.xml EX-101.CAL 41502
8 EX-101.DEF immu-20160930_def.xml EX-101.DEF 117743
9 EX-101.LAB immu-20160930_lab.xml EX-101.LAB 310108
10 EX-101.PRE immu-20160930_pre.xml EX-101.PRE 257014
Mailing Address 300 AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address 300 AMERICAN RD MORRIS PLAINS NJ 07950 9736058200
IMMUNOMEDICS INC (Filer) CIK: 0000722830 (see all company filings)

IRS No.: 611009366 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-12104 | Film No.: 161968694
SIC: 2835 In Vitro & In Vivo Diagnostic Substances